REGENERON PHARMACEUTICALS, INC.

Organization

Tarrytown, NY, US

Ticker Symbols

NASDAQ:REGN

PHARMACEUTICAL PREPARATIONS
Business Address
777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9143477000
Mailing Address
777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
State Location
NY
State of Incorporation
NY

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Taurine supplemented cell culture medium and methods of use
- Patent number 12,221,619
- Issue date Feb 11, 2025
- Regeneron Pharmaceuticals Inc.
- Amy S. Johnson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for expressing factor IX
- Patent number 12,214,023
- Issue date Feb 4, 2025
- Intellia Therapeutics, Inc.
- Jonathan Douglas Finn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof
- Patent number 12,215,131
- Issue date Feb 4, 2025
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen binding molecule formats
- Patent number 12,215,148
- Issue date Feb 4, 2025
- REGENERON PHARMACEUTICALS, INC.
- Tong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for internalizing enzymes
- Patent number 12,215,138
- Issue date Feb 4, 2025
- REGENERON PHARMACEUTICALS, INC.
- Andrew Baik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of liver disease with mitochondrial glycerol-3-phosphate...
- Patent number 12,215,322
- Issue date Feb 4, 2025
- REGENERON PHARMACEUTICALS, INC.
- Luca Andrea Lotta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods relating to detection, inhibition, and ima...
- Patent number 12,216,122
- Issue date Feb 4, 2025
- REGENERON PHARMACEUTICALS, INC.
- Heather Dawn Agnew
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ADAM6 mice
- Patent number 12,207,628
- Issue date Jan 28, 2025
- REGENERON PHARMACEUTICALS, INC.
- Lynn Macdonald
- B60 - VEHICLES IN GENERAL
Information Patent Grant
CRISPR/Cas screening platform to identify genetic modifiers of tau...
- Patent number 12,209,238
- Issue date Jan 28, 2025
- REGENERON PHARMACEUTICALS, INC.
- Marine Prissette
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bis-octahydrophenanthrene carboxamide derivatives and protein conju...
- Patent number 12,209,180
- Issue date Jan 28, 2025
- REGENERON PHARMACEUTICALS, INC.
- Jesper A. Gromada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-VEGF protein compositions and methods for producing the same
- Patent number 12,202,883
- Issue date Jan 21, 2025
- REGENERON PHARMACEUTICALS, INC.
- Andrew Tustian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-human animals comprising a humanized coagulation factor 12 locus
- Patent number 12,201,096
- Issue date Jan 21, 2025
- REGENERON PHARMACEUTICALS, INC.
- Yajun Tang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of inflammatory conditions by delivery of interleukin-1 r...
- Patent number 12,201,673
- Issue date Jan 21, 2025
- REGENERON PHARMACEUTICALS, INC.
- Eben Tessari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of LC-MS/MS to quantitate protein biomarkers
- Patent number 12,196,761
- Issue date Jan 14, 2025
- REGENERON PHARMACEUTICALS, INC.
- Sook Yen E
- G01 - MEASURING TESTING
Information Patent Grant
Retainer adapter assembly
- Patent number D1057944
- Issue date Jan 14, 2025
- REGENERON PHARMACEUTICALS, INC.
- Christopher Hunter
- D24 - Medical and laboratory equipment
Information Patent Grant
IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer
- Patent number 12,187,792
- Issue date Jan 7, 2025
- REGENERON PHARMACEUTICALS, INC.
- Caroline Liot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating skin cancer with histidine ammonia-lyase (HAL)...
- Patent number 12,186,378
- Issue date Jan 7, 2025
- REGENERON PHARMACEUTICALS, INC.
- Manuel Allen Revez Ferreira
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IL10 agonists and methods of use thereof
- Patent number 12,187,772
- Issue date Jan 7, 2025
- REGENERON PHARMACEUTICALS, INC.
- Jie Dai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen binding molecule formats
- Patent number 12,180,272
- Issue date Dec 31, 2024
- REGENERON PHARMACEUTICALS, INC.
- Tong Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
System and method of analysis of a protein using liquid chromatogra...
- Patent number 12,174,199
- Issue date Dec 24, 2024
- REGENERON PHARMACEUTICALS, INC.
- Shunhai Wang
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Grant
System and method for characterizing protein dimerization
- Patent number 12,174,173
- Issue date Dec 24, 2024
- REGENERON PHARMACEUTICALS, INC.
- Shunhai Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for assessing binding affinity of an antibody variant to th...
- Patent number 12,172,106
- Issue date Dec 24, 2024
- REGENERON PHARMACEUTICALS, INC.
- Hongxia Wang
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Activity based host cell protein profiling
- Patent number 12,169,199
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Haibo Qiu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating angiogenic eye disorders with high doses of VE...
- Patent number 12,168,036
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Kenneth S. Graham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Native microfluidic CE-MS analysis of antibody charge heterogeneity
- Patent number 12,169,203
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Hongxia Wang
- G01 - MEASURING TESTING
Information Patent Grant
Coupled native mass spectrometry for antibody analysis
- Patent number 12,169,204
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Yuetian Yan
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Grant
Il-2 variants with reduced binding to IL-2 receptor alpha and uses...
- Patent number 12,168,681
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piezo type mechanosensitive ion channel component 1 (PIEZO1) varian...
- Patent number 12,163,192
- Issue date Dec 10, 2024
- REGENERON PHARMACEUTICALS, INC.
- Joshua Backman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
High affinity human antibodies to human IL-4 receptor
- Patent number 12,162,943
- Issue date Dec 10, 2024
- REGENERON PHARMACEUTICALS, INC.
- Joel H. Martin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Non-human animals having a humanized signal-regulatory protein gene
- Patent number 12,161,097
- Issue date Dec 10, 2024
- REGENERON PHARMACEUTICALS, INC.
- Andrew J. Murphy
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
Methods of Treating Multiple Myeloma with Bispecific Anti-BCMA x An...
- Publication number 20250051466
- Publication date Feb 13, 2025
- Regeneron Pharmaceuticals, Inc.
- Israel Lowy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TFR:ACID SPHINGOMYELINASE FOR TREATMENT OF ACID SPHINGOMYELINA...
- Publication number 20250049896
- Publication date Feb 13, 2025
- Regeneron Pharmaceuticals, Inc.
- Maria Praggastis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR
- Publication number 20250051465
- Publication date Feb 13, 2025
- Regeneron Pharmaceuticals, Inc.
- Jesper GROMADA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HUMAN ANIMALS COMPRISING HUMANIZED ACE2 AND TMPRSS LOCI
- Publication number 20250049006
- Publication date Feb 13, 2025
- Regeneron Pharmaceuticals, Inc.
- Susannah Brydges
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Stabilized Formulations Containing Anti-BCMA x Anti-CD3 Bispecific...
- Publication number 20250041411
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Kenneth S. Graham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TFR:GAA AND ANTI-CD63:GAA INSERTION FOR TREATMENT OF POMPE DIS...
- Publication number 20250041455
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Andrew Baik
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...
- Publication number 20250042999
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Jessica R. Kirshner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC PD-L1xCD28 ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20250043002
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Saida Dadi-Mehmetaj
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUTANT MYOCILIN DISEASE MODEL AND USES THEREOF
- Publication number 20250040522
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Gaurang Patel
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC PD-L1x4-1BB ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20250043017
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Saida Dadi-Mehmetaj
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
- Publication number 20250042972
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Eric FURFINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN-ANTIVIRAL COMPOUND CONJUGATES
- Publication number 20250041433
- Publication date Feb 6, 2025
- Regeneron Pharmaceuticals, Inc.
- Thomas NITTOLI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20250034224
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TANDEM MASS TAG MULTIPLEXED QUANTITATION OF POST-TRANSLATIONAL MODI...
- Publication number 20250035642
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Yuan Mao
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF EFFECTING A HEMODYNAMIC CHANGE BY ADMINISTERING AN ANTI-...
- Publication number 20250034279
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Michael E. DUNN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS
- Publication number 20250032642
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Andrew Baik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME
- Publication number 20250034231
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Shunhai Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (...
- Publication number 20250032529
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Harikiran Nistala
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNBIASED AND HIGH-THROUGHPUT IDENTIFICATION AND QUANTIFICATION OF H...
- Publication number 20250035643
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Haibo Qiu
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Application
METHODOLOGY TO CHARACTERIZE EMPTY-FULL RATIO IN CRUDE AAV SAMPLES
- Publication number 20250035532
- Publication date Jan 30, 2025
- Regeneron Pharmaceuticals, Inc.
- Deepanshu Choudhary
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
CD79A CHIMERIC ANTIGEN RECEPTORS
- Publication number 20250026828
- Publication date Jan 23, 2025
- Regeneron Pharmaceuticals, Inc.
- Kevin Friedman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYSTEMS AND METHODS FOR MOTOR ASSESSMENT
- Publication number 20250025067
- Publication date Jan 23, 2025
- Regeneron Pharmaceuticals, Inc.
- Shawn Luke MISHRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Extended, High Dose VEGF Antagonist Regimens for Treatment of Angio...
- Publication number 20250025531
- Publication date Jan 23, 2025
- Regeneron Pharmaceuticals, Inc.
- Robert L. Vitti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND SYSTEMS FOR DETECTION OF ABNORMAL KARYOTYPES
- Publication number 20250027156
- Publication date Jan 23, 2025
- Regeneron Pharmaceuticals, Inc.
- Evan Maxwell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NON-HUMAN ANIMALS COMPRISING A MODIFIED CACNG1 LOCUS
- Publication number 20250017183
- Publication date Jan 16, 2025
- Regeneron Pharmaceuticals, Inc.
- Trevor Stitt
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Methods Of Treating Skin Cancer With Carboxypeptidase Vitellogenic...
- Publication number 20250017929
- Publication date Jan 16, 2025
- Regeneron Pharmaceuticals, Inc.
- Xinyuan Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-IL36R ANTIBODIES
- Publication number 20250011442
- Publication date Jan 9, 2025
- Regeneron Pharmaceuticals, Inc.
- Jeanette Fairhurst
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR REDUCING CENTRALIZED PAIN
- Publication number 20250011408
- Publication date Jan 9, 2025
- Regeneron Pharmaceuticals, Inc.
- Stephen DIMARTINO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CIRCULARIZED ANTIBODY MOLECULES
- Publication number 20250011449
- Publication date Jan 9, 2025
- Regeneron Pharmaceuticals, Inc.
- Tri NGUYEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ADOPTIVE CELLULAR THERAPY
- Publication number 20250009822
- Publication date Jan 9, 2025
- Regeneron Pharmaceuticals, Inc.
- James Brian Rottman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
99042734 - MAZUJIC
- Serial number 99042734
- Filing date Feb 14, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99042744 - MUZABRA
- Serial number 99042744
- Filing date Feb 14, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99031257 - VYONFRI
- Serial number 99031257
- Filing date Feb 6, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99031331 - SYMNOTE
- Serial number 99031331
- Filing date Feb 6, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99031388 - SONIQOTO
- Serial number 99031388
- Filing date Feb 6, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99031311 - BEAUSOTO
- Serial number 99031311
- Filing date Feb 6, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99031363 - SEMCHIME
- Serial number 99031363
- Filing date Feb 6, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99031402 - MESONDLY
- Serial number 99031402
- Filing date Feb 6, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99029205 - OTVOXVY
- Serial number 99029205
- Filing date Feb 5, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99029214 - AUMENOTO
- Serial number 99029214
- Filing date Feb 5, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99026925 - ZARMENY
- Serial number 99026925
- Filing date Feb 3, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99026889 - LUZNOTO
- Serial number 99026889
- Filing date Feb 3, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99026851 - EMNOTA
- Serial number 99026851
- Filing date Feb 3, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99026912 - MELZONIX
- Serial number 99026912
- Filing date Feb 3, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021240 - OTARMENI
- Serial number 99021240
- Filing date Jan 28, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021213 - VIONFRI
- Serial number 99021213
- Filing date Jan 28, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99017427 - OTOVISTRY
- Serial number 99017427
- Filing date Jan 24, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99017374 - TYMFORIA
- Serial number 99017374
- Filing date Jan 24, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99017291 - MELAUDYC
- Serial number 99017291
- Filing date Jan 24, 2025
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98844359 - FOPRYSE
- Serial number 98844359
- Filing date Nov 8, 2024
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98789277 - TIVOLZA
- Serial number 98789277
- Filing date Oct 7, 2024
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98784459 - FOPRYZE
- Serial number 98784459
- Filing date Oct 3, 2024
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98754628 - HAPILTO
- Serial number 98754628
- Filing date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98652297 - REGENERON
- Serial number 98652297
- Filing date Jul 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
Information Trademark
98625063 - REGENERON CELL MEDICINES
- Serial number 98625063
- Filing date Jul 4, 2024
- REGENERON PHARMACEUTICALS, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98623320 - MY EVKEEZA DROP
- Serial number 98623320
- Filing date Jun 27, 2024
- REGENERON PHARMACEUTICALS, INC.
- 44 - Medical services
Information Trademark
98623315 - MY EVKEEZA DROP
- Serial number 98623315
- Filing date Jun 27, 2024
- REGENERON PHARMACEUTICALS, INC.
- 44 - Medical services
Information Trademark
98542694 - EYLEA HD AHEAD
- Serial number 98542694
- Registration number 7686993
- Filing date May 9, 2024
- REGENERON PHARMACEUTICALS, INC.
- 44 - Medical services
Information Trademark
98506045 - LYNOZYFIC SURROUND
- Serial number 98506045
- Filing date Apr 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- 35 - Advertising
Information Trademark
98486023 - EYEGM
- Serial number 98486023
- Filing date Apr 5, 2024
- REGENERON PHARMACEUTICALS, INC.
- 42 - Scientific and technological services and research and design relating thereto

NIH Research Projectlast 12 months

processing...

Count: 6

Research Projects

Information Research Project
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 E...
- Application id 7901141
- Award notice date Aug 28, 2010
Information Research Project
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 E...
- Application id 7935903
- Award notice date Sep 29, 2009
Information Research Project
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 E...
- Application id 7685504
- Award notice date Jul 23, 2009
Information Research Project
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 E...
- Application id 7496638
- Award notice date Sep 8, 2008
Information Research Project
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 E...
- Application id 7284842
- Award notice date Sep 12, 2007
Information Research Project
Production of Targeted Null Mutations for 10,000 Genes in C57BL/6 E...
- Application id 7152399
- Award notice date Sep 6, 2006

REGENERON PHARMACEUTICALS, INC.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Taurine supplemented cell culture medium and methods of use

Compositions and methods for expressing factor IX

IgG Fc-IL2-Rα-IL2 fusions and methods of use thereof

Antigen binding molecule formats

Compositions and methods for internalizing enzymes

Treatment of liver disease with mitochondrial glycerol-3-phosphate...

Compositions and methods relating to detection, inhibition, and ima...

ADAM6 mice

CRISPR/Cas screening platform to identify genetic modifiers of tau...

Bis-octahydrophenanthrene carboxamide derivatives and protein conju...

Anti-VEGF protein compositions and methods for producing the same

Non-human animals comprising a humanized coagulation factor 12 locus

Treatment of inflammatory conditions by delivery of interleukin-1 r...

Use of LC-MS/MS to quantitate protein biomarkers

Retainer adapter assembly

IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer

Methods of treating skin cancer with histidine ammonia-lyase (HAL)...

IL10 agonists and methods of use thereof

Antigen binding molecule formats

System and method of analysis of a protein using liquid chromatogra...

System and method for characterizing protein dimerization

Methods for assessing binding affinity of an antibody variant to th...

Activity based host cell protein profiling

Methods for treating angiogenic eye disorders with high doses of VE...

Native microfluidic CE-MS analysis of antibody charge heterogeneity

Coupled native mass spectrometry for antibody analysis

Il-2 variants with reduced binding to IL-2 receptor alpha and uses...

Piezo type mechanosensitive ion channel component 1 (PIEZO1) varian...

High affinity human antibodies to human IL-4 receptor

Non-human animals having a humanized signal-regulatory protein gene

Patents Applicationslast 30 patents

Methods of Treating Multiple Myeloma with Bispecific Anti-BCMA x An...

ANTI-TFR:ACID SPHINGOMYELINASE FOR TREATMENT OF ACID SPHINGOMYELINA...

ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR

NON-HUMAN ANIMALS COMPRISING HUMANIZED ACE2 AND TMPRSS LOCI

Stabilized Formulations Containing Anti-BCMA x Anti-CD3 Bispecific...

ANTI-TFR:GAA AND ANTI-CD63:GAA INSERTION FOR TREATMENT OF POMPE DIS...

USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3...

BISPECIFIC PD-L1xCD28 ANTIBODIES AND METHODS OF USE THEREOF

MUTANT MYOCILIN DISEASE MODEL AND USES THEREOF

BISPECIFIC PD-L1x4-1BB ANTIBODIES AND METHODS OF USE THEREOF

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

PROTEIN-ANTIVIRAL COMPOUND CONJUGATES

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

TANDEM MASS TAG MULTIPLEXED QUANTITATION OF POST-TRANSLATIONAL MODI...

METHODS OF EFFECTING A HEMODYNAMIC CHANGE BY ADMINISTERING AN ANTI-...

CRISPR-MEDIATED TRANSGENE INSERTION IN NEONATAL CELLS

ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME

Treatment Of Hyperglycemia With Solute Carrier Family 39 Member 5 (...

UNBIASED AND HIGH-THROUGHPUT IDENTIFICATION AND QUANTIFICATION OF H...

METHODOLOGY TO CHARACTERIZE EMPTY-FULL RATIO IN CRUDE AAV SAMPLES

CD79A CHIMERIC ANTIGEN RECEPTORS

SYSTEMS AND METHODS FOR MOTOR ASSESSMENT

Extended, High Dose VEGF Antagonist Regimens for Treatment of Angio...

METHODS AND SYSTEMS FOR DETECTION OF ABNORMAL KARYOTYPES

NON-HUMAN ANIMALS COMPRISING A MODIFIED CACNG1 LOCUS

Methods Of Treating Skin Cancer With Carboxypeptidase Vitellogenic...

ANTI-IL36R ANTIBODIES

METHODS AND COMPOSITIONS FOR REDUCING CENTRALIZED PAIN

CIRCULARIZED ANTIBODY MOLECULES

ADOPTIVE CELLULAR THERAPY

Trademarklast 30 trademarks

99042734 - MAZUJIC

99042744 - MUZABRA

99031257 - VYONFRI

99031331 - SYMNOTE

99031388 - SONIQOTO

99031311 - BEAUSOTO

99031363 - SEMCHIME

99031402 - MESONDLY

99029205 - OTVOXVY

99029214 - AUMENOTO